Connect Biopharma Holdings (CNTB) Current Leases (2023 - 2026)

Connect Biopharma Holdings has disclosed Current Leases across 4 years of filings, most recently posting $393000.0 for Q2 2026.

• In Q2 2026, Current Leases rose 12.29% year-over-year to $393000.0; the TTM figure through Jun 2026 stood at $393000.0 (up 12.29% YoY), while the FY2025 annual figure was $322000.0, up 109.09% from the prior year.
• Current Leases came in at $393000.0 for Q2 2026 at Connect Biopharma Holdings, down from $406000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $406000.0 in Q1 2026 to a low of $154000.0 in Q4 2024.
• Average Current Leases over 4 years is $324000.0, with a median of $341000.0 recorded in 2025.
• Year-over-year, Current Leases plunged 45.96% in 2024 and surged 109.09% in 2025.
• Over 4 years, Current Leases stood at $285000.0 in 2023, then sank by 45.96% to $154000.0 in 2024, then surged by 109.09% to $322000.0 in 2025, then grew by 22.05% to $393000.0 in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $393000.0 in Q2 2026, $406000.0 in Q1 2026, and $322000.0 in Q4 2025.